AI
By
Is Novartis Deepening Its Bet on AI-Enabled Molecular Glue Degraders Through an Expanded Collaboration With Monte Rosa?
Novartis AG (SIX: NOVN; NYSE: NVS), a global leader in immunology and targeted therapies, has broadened its partnership…
Will Levita’s MARS Platform Redefine Solo Surgery with Autonomous Camera Integration?
Key Highlights: Autonomous Camera Enables Solo Laparoscopic Surgery At Clínica Las Condes in Santiago, Chile, a gallbladder removal…
Will Tempus AI’s FDA Clearance Redefine the Future of Cardiac Imaging?
Key Highlights: Tempus AI Secures FDA Clearance for Tempus Pixel Tempus AI announced that its advanced imaging platform,…
Can DeepMind’s Demis Hassabis Slash Drug Discovery Timelines From Years to Months—And What Does That Mean for Pharma Startups?
Key Highlights: What Hassabis Says: A Turning Point for Drug DiscoveryDemis Hassabis, CEO of DeepMind, recently told Bloomberg…
Can Ant Group’s AQ AI Health App Redefine Access to Quality Care for 140 Million Users Across China?
Key Highlights Expanding AI Access in HealthcareSince its launch in June 2025, Ant Group’s AQ AI Health App…
Can GHX’s AI-Driven Supply Chain Solutions Transform How Hospitals Tackle Disruptions?
Key Highlights AI reshaping healthcare supply chains: Unlike retail or tech, healthcare requires flawless delivery—any delay can directly…
